Copyright © 2015 - 2022 Lifecarenews.in
LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
ALS
Ractigen Therapeutics Receives FDA Orphan Drug Designation
<!-- Name:DistributionId Value:8781126 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value:4570 -->…
Masitinib receives orphan drug status for the treatment of
PRESS RELEASE MASITINIB RECEIVES ORPHAN DRUG STATUS FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) IN SWITZERLAND Paris, December 27, 2022, 7pm CET AB Science SA (Euronext - FR0010557264 - AB) today announces that masitinib…